Related Experiment Video
Updated: Dec 28, 2025

Ex Vivo Intestinal Sacs to Assess Mucosal Permeability in Models of Gastrointestinal Disease
Published on: February 9, 2016
Recent Advancements in Using Polymers for Intestinal Mucoadhesion and Mucopenetration
Essi Taipaleenmäki1, Brigitte Städler1
1Interdisciplinary Nanoscience Center (iNANO), Gustav Wieds Vej 14, 8000, Aarhus, Denmark.
Recent advancements in polymer-based drug delivery focus on overcoming intestinal mucus barriers. Innovations include mucopenetrating nanoparticles and mucoadhesive polymers for enhanced oral active delivery.
Area of Science:
- Biomaterials Science
- Drug Delivery Systems
- Nanotechnology
Background:
- Oral drug administration is preferred but hindered by the intestinal mucus layer.
- Effective drug delivery requires overcoming this barrier for therapeutic success.
Purpose of the Study:
- To summarize recent (2-3 years) developments in polymer-based formulations for oral drug delivery.
- To highlight strategies for enhancing drug penetration and adhesion within the intestinal mucus.
Main Methods:
- Review of polymer-based nanoparticles with mucopenetrating coatings (noninteracting polymers, virus-like particles, charge-shifting particles).
- Discussion of polymer modifications for improved mucoadhesion.
- Analysis of double-encapsulation systems combining mucopenetration and mucoadhesion.
Main Results:
- Progress in designing nanoparticles that can penetrate the intestinal mucus layer.
- Development of polymers and systems to enhance drug retention at the intestinal surface.
- Emergence of dual-function systems for combined mucus penetration and adhesion.
Conclusions:
- Polymer-based formulations show significant promise for overcoming intestinal mucus barriers.
- Further research is needed to address remaining challenges in oral drug delivery systems.
Related Concept Videos
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
Bioavailability Enhancement: Drug Permeability Enhancement
Factors Affecting Dissolution: Drug Permeability, Stability and Stereochemistry
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...

